欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/H/2072/002
药品名称Rabeprazolnatrium 20 mg Focus, maagsapresistente tabletten
活性成分
    • rabeprazole sodium salt 20.0 mg
剂型Gastro-resistant tablet
上市许可持有人Focus Care Pharmaceuticals BV Lagedijk 1-3 1541 KA Koog a/d Zaan The Netherlands
参考成员国 - 产品名称Netherlands (NL)
Rabeprazolnatrium Chemo Iberica 20 mg maagsapresistente tabletten
互认成员国 - 产品名称
    • Spain (ES)
    • Hungary (HU)
      RABEPRAZOLE CHEMO IBERICA 20 mg gyomornedv-ellenálló tabletta
    • Slovenia (SI)
      Rabeprazol Chemo Iberica 20 mg gastrorezistentne tablete
许可日期2011/06/15
最近更新日期2024/03/12
药物ATC编码
    • A02BC04 rabeprazole
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase